IDEAYA Biosciences Inc (NAS:IDYA)
$ 30.98 -1 (-3.13%) Market Cap: 2.68 Bil Enterprise Value: 1.86 Bil PE Ratio: 0 PB Ratio: 2.27 GF Score: 28/100

IDEAYA Biosciences Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 11, 2023 / 02:40PM GMT
Release Date Price: $28.95 (+3.36%)
Ryuk Byun
Morgan Stanley - Analyst

Great. Thank you, everyone, for coming today. My name is Ryuk Byun. I'm an Executive Director with the investment banking division at Morgan Stanley. Before we get started, I just need to read a quick disclosure. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.

So we have the pleasure of hosting IDEAYA management team today for the fireside chat. We have Yujiro and Paul from the company. Thank you for making the trip out here from California, which wasn't easy, and we really appreciate your time here today.

Questions & Answers

Ryuk Byun;Yujiro Hata
Morgan Stanley - Analyst;IDEAYA

So maybe just to get us kicked off here Yujiro, can you just start by taking us through IDEAYA's pipeline and your oncology platforms?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot